J. Safra Asset Management’s Novo Nordisk NVO Stock Holding History

J. Safra Asset Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$17.1K	Hold	466	–	–	﹤0.01%	322
2025 Q4	$23.7K	Buy	+466	New	+$23.8K	﹤0.01%	312
2024 Q3	–	Sell	-968	Closed	-$138K	–	316
2024 Q2	$138K	Buy	968 +634	+190%	+$84K	0.01%	78
2024 Q1	$42.9K	Buy	334 +293	+715%	+$34.9K	﹤0.01%	95
2023 Q4	$4.24K	Buy	+41	New	+$4.05K	﹤0.01%	111
2016 Q3	–	Sell	-4,730	Closed	-$127K	–	211
2016 Q2	$127K	Buy	+4,730	New	+$130K	0.21%	45

Other funds holding NVO

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

J. Safra Asset Management's NVO Position: Q1 2026 in Review

J. Safra Asset Management held its Novo Nordisk (NVO) position steady in Q1 2026 at 466 shares worth $17.1K. The position accounts for ﹤0.01% of the portfolio, ranked #322.

J. Safra Asset Management first reported a position in NVO in Q2 2016 and has held it in 6 quarters since. The position peaked at $138K in Q2 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

J. Safra Asset Management held 466 shares of Novo Nordisk worth $17.1K as of Q1 2026.
J. Safra Asset Management left its Novo Nordisk share count unchanged in Q1 2026.
Novo Nordisk made up ﹤0.01% of J. Safra Asset Management's portfolio in Q1 2026, its #322 holding.
J. Safra Asset Management first reported a position in Novo Nordisk in Q2 2016 and has held it in 6 quarters since.
J. Safra Asset Management's Novo Nordisk position peaked at $138K in Q2 2024.
1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on J. Safra Asset Management's 13F filing for Q1 2026, filed 4 May 2026.